According to Amylyx Pharmaceuticals's latest financial reports the company's total assets are $0.51 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.51 B | 32.19% |
2022-12-31 | $0.39 B | 270.64% |
2021-12-31 | $0.10 B | 648.82% |
2020-12-31 | $14.1 M | 338.01% |
2019-12-31 | $3.22 M |